Jam
-
Argo Places First Graphene Purchase Order
Argo Living Soils Corp. is entering the advanced construction materials sector with its first supply order of liquid graphene oxide. This high-grade product, derived from pure vein graphite, will be integrated into concrete formulations to enhance performance and sustainability. The company also announced marketing and investor relations initiatives to boost its profile.
-
Endeavour to Release Q2 and First Half 2025 Results on July 31, 2025
Endeavour Mining will announce its Q2 and half-year 2025 financial results on July 31, 2025, before the London Stock Exchange opens. A conference call and webcast will follow at 8:30 AM EDT / 1:30 PM BST, with playback available on the company’s website. Investor relations contact is Jack Garman.
-
KKR Launches Singapore-Based Ascend Asia Financial Advisory Platform
KKR has launched Ascend Asia, a new financial advisory platform in Singapore, led by former Prudential Singapore CEO Tomas Urbanec. Ascend Asia acquired finexis advisory, making it the platform’s first member. The initiative aims to elevate financial advisory services in Singapore through enhanced client service, best practices, and strategic resources for member firms.
-
Golden Goliath Resources Announces Board Resignation
Golden Goliath Resources Ltd. announced the immediate resignation of Mr. Daniel Nofrietta Fernandez from its Board of Directors. The company expressed gratitude for his contributions and is actively seeking replacements as part of a strategic review to enhance shareholder value and guide future growth.
-
TELUS Prices Tender Offers for Eight Debt Series
TELUS Corporation has finalized pricing for its cash tender offers to repurchase outstanding notes. This strategic debt management move specifies terms for various series of senior notes maturing between 2030 and 2051. The company expects to settle these transactions on July 3, 2025. RBC Dominion Securities Inc. and others are managing the offers.
-
Tutor Perini Wins $1.87 Billion Midtown Bus Terminal Staging and Storage Project
Tutor Perini Corporation has been awarded a $1.87 billion contract by the Port Authority of New York and New Jersey for the Midtown Bus Terminal Redevelopment Program. The project includes constructing a seven-story bus storage facility and a ramp structure to facilitate bus movement. Construction is set to begin in fall 2025, with completion of funded portions expected by fall 2028.
-
Toll Brothers Announces Final Homes Available at Murphy’s Crescent Hill
Toll Brothers announces a final opportunity to purchase a luxury home at Crescent Hill in Murphy, Texas. This community offers spacious one- and two-story designs with 4-6 bedrooms and upscale finishes, priced from the mid-$700,000s. Residents benefit from the Plano school district and convenient access to amenities. Quick move-in homes are available.
-
ANGLE PLC: 2025 AGM Results Announced
ANGLE plc announced all resolutions were passed at its 2025 Annual General Meeting. The global leader in liquid biopsy technology, known for its Parsortix® PC1 System, focuses on circulating tumor cell (CTC) solutions for research, drug development, and clinical oncology. The company offers clinical services and diagnostic products, backed by over 100 peer-reviewed publications.
-
Robinhood’s Crypto Expansion: Stock Tokens, Layer 2, EU/US Futures & Staking
Robinhood is expanding its global reach with stock and ETF tokens for EU investors, marking a significant entry into the European market. The company is also developing its own Layer 2 blockchain for tokenized assets. Additionally, Robinhood is launching crypto perpetual futures in the EU and crypto staking for US customers, further broadening its crypto offerings and aiming to make investing more accessible worldwide.
-
Ravi Kapoor Joins SOHM, Inc. Board as Independent Director
SOHM, Inc. appointed Ravi Kapoor as an Independent Director. Kapoor brings over 30 years of experience in corporate law, M&A, and financial management. His expertise is expected to enhance SOHM’s strategic direction, corporate governance, and growth initiatives, particularly aligning with the company’s focus on generic drugs and gene-editing technologies.